Latest pulmonary disease News | Page 4

How old are your internal organs?
Scientists build human lungs in dish to test medicines
First cohort of community pharmacists embarks on university course today for the North Queensland Community Pharmacy Scope of Practice Pilot
Our Make Smoking History team launch ‘Sounds Like’ campaign
A heated debate – how safe are gas stoves?
Heated debate – how safe are gas stoves?
Women with satisfying relationships tend to have fewer chronic illnesses
Researchers call for prescription charge to be cut
Discovery could open door to new COPD treatment
Innovative digital platform to diagnose and treat breathlessness receives $1.87m grant
NIH funds antibiotic trial for HIV and emphysema
Burden of ill health increases in Australia
Researchers discover why viral infections are worse for people with COPD
PT027 recommended by FDA advisory committee as new rescue treatment for asthma
Update on MESSINA Phase III trial for Fasenra in eosinophilic esophagitis
North Queensland pilot program to deliver more effective primary health care
Voice screening App delivers rapid results for Parkinson’s and severe COVID
Tezspire approved in Japan for treatment of severe asthma
UQ startup acquired by Pfizer
Tezspire approved in EU for treatment of severe asthma
World first online singing trial for people with chronic lung disease
Dimerix confirms CLARITY 2.0 Covid study concludes recruitment
MinterEllison advises on Medical Developments’ capital raising
DImerix announces new patient family for DMX-700
Can you get sick from being cold?
Recruitment open for new study of lung disease
New options for health, environmental monitoring with water-resistant gas sensor
Virtual lung therapy by smartphone app rivals traditional method
Tezspire recommended for approval in EU by CHMP for treatment of severe asthma
Australia’s first national biotechnology incubator announces round one funding
Monash projects backed by Australia’s national biotech incubator
Dimerix updates with new and positive DMX-700 data
New drug target identified for inflammatory lung disease
COPD patients respond equally well to Covid vaccine
Tips to cope with Saharan dust
New projects announced for National Drug Discovery Centre
Sleep relief for lung disease
World-first study reveals why people with COPD are more susceptible to Covid
Cochrane Review highlights need for new interventions to improve chronic obstructive pulmonary disease
$10 million investment fuels promising treatments for inflammatory lung disease
Researcher founding scientist of new biotech company launched with AUD$10m investment
Dimerix receives R&D tax rebate for last financial year
Pharmac deal good news for New Zealanders
Update on US regulatory review of Fasenra in chronic rhinosinusitis with nasal polyps
Life-saving medicines unaffordable as PBS co-pay heads to $50 script
Why inflammation is important
ATAGI recommendations on use of Spikevax Covid vaccine in children aged 6 to 11 years
AstraZeneca progresses Ambition Zero Carbon programme with Honeywell partnership to develop next-generation respiratory inhalers